Extracorporeal Membrane Oxygenation Machine Market Report
First published: 11 October 2024 | Last updated: 25 May 2026 | Report Code: extracorporeal-membrane-oxygenation-machine
Extracorporeal Membrane Oxygenation Machine Market — USD 2.5 billion in 2023, Growing to USD 5.16B by 2033 at 7.3% CAGR
This report provides an in-depth analysis of the Extracorporeal Membrane Oxygenation (ECMO) Machine market, focusing on current trends, market size, growth forecasts from 2023 to 2033, industry insights, and regional analyses.
Key Takeaways
- Global market grows from $2.50 Billion in 2023 to $5.16 Billion in 2033 at a 7.3% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe increases from $0.77 Billion in 2023 to $1.59 Billion in 2033, reflecting steady clinical uptake.
- Asia Pacific advances from $0.41 Billion to $0.85 Billion, driven by expanding critical care infrastructure.
- Leading vendors include Getinge AB, Maquet Getinge Holding B.V., Medtronic, Terumo Corporation, and Fresenius SE & Co. KGaA.
Extracorporeal Membrane Oxygenation Machine Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The market for extracorporeal membrane oxygenation machines is set for sustained expansion between 2023 and 2033, with overall value increasing from $2.50 Billion to $5.16 Billion and a 7.3% CAGR. Demand is being supported by rising incidence of severe cardiac and respiratory conditions, broader clinical acceptance, and continuous device innovation. Hospitals and specialty clinics remain primary end users, while product differentiation across ECMO circuitry, pump types and accessories is increasing. Regional variation is notable: North America leads in absolute market size. Key vendors such as Getinge AB, Maquet Getinge Holding B.V., Medtronic, Terumo Corporation and Fresenius SE & Co. KGaA play prominent roles through product portfolios and partnerships. The report structure covers market dynamics, segmentation by technology and application, regional performance, and competitive positioning to inform procurement, investment, and R&D decisions.
Key Growth Drivers
- Rising prevalence of severe respiratory and cardiac failures increasing clinical demand for ECMO support devices.
- Technological improvements in circuits and pump systems enhancing safety, portability, and treatment outcomes.
- Greater adoption in intensive care settings and specialty clinics as clinicians recognize ECMO benefits for critical patients.
- Investment by leading manufacturers and collaboration with healthcare providers to expand product availability and training.
- Expansion of critical care infrastructure in emerging markets supporting higher device deployment and utilization.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 7.3% |
| 2033 Market Size | $5.16 Billion |
| Top Companies | Getinge AB, Maquet Getinge Holding B.V., Medtronic , Terumo Corporation, Fresenius SE & Co. KGaA |
| Published Date | 11 October 2024 |
| Last Modified Date | 25 May 2026 |
Extracorporeal Membrane Oxygenation Machine Market Overview
Customize Extracorporeal Membrane Oxygenation Machine Market Report market research report
- ✔ Get in-depth analysis of Extracorporeal Membrane Oxygenation Machine market size, growth, and forecasts.
- ✔ Understand Extracorporeal Membrane Oxygenation Machine's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Extracorporeal Membrane Oxygenation Machine
What is the Market Size & CAGR of Extracorporeal Membrane Oxygenation Machine Market Report market in 2023?
Extracorporeal Membrane Oxygenation Machine Industry Analysis
Extracorporeal Membrane Oxygenation Machine Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Extracorporeal Membrane Oxygenation Machine Market Report Market Analysis Report by Region
Europe Extracorporeal Membrane Oxygenation Machine Market Report:
Europe grows from $0.77 Billion in 2023 to $1.59 Billion in 2033. 77 Billion in 2023 to $1.59 Billion in 2033, supported by improving ICU capacities, rising clinician familiarity with ECMO therapies, and regulatory environments that enable broader clinical application.Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Report:
Asia Pacific grows from $0.41 Billion in 2023 to $0.85 Billion in 2033. 41 Billion in 2023 to $0.85 Billion in 2033, driven by investments in hospital systems, increased access to advanced life-support equipment, and expanding training for intensive care clinicians.North America Extracorporeal Membrane Oxygenation Machine Market Report:
North America is largest regional market, rising from $0.95 Billion in 2023 to $1.97 Billion in 2033. This expansion reflects established critical care infrastructure, extensive hospital adoption, and active participation by major suppliers in clinical programs and product development.South America Extracorporeal Membrane Oxygenation Machine Market Report:
Latin America grows from $0.2 Billion in 2023 to $0.42 Billion in 2033. 2 Billion in 2023 to $0.42 Billion in 2033, reflecting gradual build-out of specialized care facilities and increased procurement of ECMO systems for critical care centers.Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market Report:
Middle East and Africa grows from $0.16 Billion in 2023 to $0.33 Billion in 2033. 16 Billion in 2023 to $0.33 Billion in 2033, supported by selective investments in tertiary care hospitals and growing demand for advanced respiratory and cardiac support solutions.Tell us your focus area and get a customized research report.
Research Methodology
Extracorporeal Membrane Oxygenation Machine Market Analysis By Product Type
The product type segmentation of the ECMO machine market reveals significant variances in market share and growth potential. For 2023, the Veno-arterial ECMO accounts for approximately 86.86% of the market share, valued at $2.17 billion and expected to reach $4.48 billion by 2033. In contrast, the Veno-venous ECMO segment holds a smaller share but is projected to experience steady growth, potentially increasing from $0.33 billion in 2023 to $0.68 billion by 2033.
Extracorporeal Membrane Oxygenation Machine Market Analysis By Application
The ECMO market application segments include cardiac and respiratory support. The cardiac support application significantly dominates, contributing $1.56 billion in 2023 and expected to increase to $3.22 billion by 2033. Respiratory support also holds a crucial segment, valued at $0.68 billion in 2023, likely to reach $1.41 billion by 2033, indicates the rising demand for ECMO solutions in critical care.
Extracorporeal Membrane Oxygenation Machine Market Analysis By End User
Hospitals remain the primary end-users of ECMO machines, accounting for approximately 62.49% market share in 2023 and expected to maintain this share through to 2033. Specialty clinics and home care facilities represent crucial emerging sectors, with plans to enhance facilities and resources, leading to an expected growth in their respective market shares.
Extracorporeal Membrane Oxygenation Machine Market Analysis By Region Requirements
Regulatory compliance remains a cornerstone of the ECMO market, affecting product development and marketing strategies. EU regulations and FDA approvals significantly influence the landscape, ensuring that ECMO devices adhere to safety and efficacy standards. Manufacturers increasingly focus on obtaining certifications to enhance market presence and credibility.
Extracorporeal Membrane Oxygenation Machine Market Analysis By Technology
Technological advancements have a profound impact on the ECMO market. Innovations include miniaturized components, improved oxygenation efficiencies, and advancements in patient monitoring systems. Emerging technologies such as artificial intelligence and machine learning are integrated to enhance functionality and performance, leading to better patient outcomes and optimized operation in clinical settings.
Extracorporeal Membrane Oxygenation Machine Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in the Extracorporeal Membrane Oxygenation Machine Industry
Getinge AB:
Getinge AB is a leading provider of ECMO machines known for its innovative technology and commitment to improving patient care through effective critical care solutions.Maquet Getinge Holding B.V.:
A division of Getinge AB, Maquet specializes in medical devices including ECMO machines and has established a strong presence in both the European and global markets.Medtronic :
Medtronic is a prominent medical technology company that provides ECMO solutions, focusing on advancing innovations in cardiac and respiratory support equipment.Terumo Corporation:
Terumo Corporation is dedicated to enhancing the quality of life for patients through its ECMO machines, emphasizing quality assurance and technological advancements.Fresenius SE & Co. KGaA:
Fresenius has a strong portfolio in medical devices and plays a vital role in the ECMO machine market by providing reliable and advanced support solutions.We're grateful to work with incredible clients.
FAQs
What is the current market size of the Extracorporeal Membrane Oxygenation Machine Market Report?
The market size was $2.50 Billion in 2023, reflecting device adoption across hospitals, specialty clinics, and growing critical care demand during the base year.
How big will the market be in 2033?
The market is projected to reach $5.16 Billion by 2033, indicating continued investment in ECMO technologies and broader clinical deployment over the forecast period.
What is CAGR for the forecast period?
The compound annual growth rate for 2023 to 2033 is 7.3%, driven by increased clinical use and ongoing product enhancements from major suppliers.
Is there a single fastest Growing region in the Extracorporeal Membrane Oxygenation Machine Market Report market?
No single fastest-growing region is stated for the Extracorporeal Membrane Oxygenation Machine Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are leading the extracorporeal membrane oxygenation machine market?
Key companies listed include Getinge AB, Maquet Getinge Holding B.V., Medtronic, Terumo Corporation, and Fresenius SE & Co. KGaA contributing through product portfolios and service networks.
What are the main clinical applications driving demand?
Primary applications include cardiac support, respiratory support, and neonatal support, with hospitals and specialty clinics being principal settings for ECMO use.
Who are the primary end users of ECMO machines?
End users comprise hospitals, specialty clinics, and home care settings, with hospitals representing the central adoption point for complex ECMO interventions.
What factors influence regional market growth?
Regional growth reflects critical care infrastructure, clinician training, regulatory pathways, and investment in advanced therapeutic technologies across healthcare systems.